Assessment and Management of Laboratory Abnormalities

Laboratory Interpretation

The American College of Physicians recommends monitoring blood glucose levels, with elevated levels indicating hyperglycemia, as seen in this patient with a blood glucose level of 101 mg/dL 1
The National Kidney Foundation suggests that decreased creatinine levels, such as 0.44 mg/dL, may indicate possible impaired renal function 2
The American College of Physicians recommends monitoring sodium levels, with low levels indicating hyponatremia, as seen in this patient with a sodium level of 130 mmol/L 1
The American College of Physicians recommends monitoring serum osmolality, which is currently 270.9 mOsm/kg, to guide fluid management 1

The American Diabetes Association recommends considering low-dose basal insulin or oral antidiabetic agents for patients with type 2 diabetes and mild hyperglycemia, with a blood glucose level of 101 mg/dL 3
The American College of Cardiology recommends targeting HbA1c levels above 7.0% in individuals with co-morbidities or limited life expectancy and risk of hypoglycemia 2
The American Association of Clinical Endocrinologists recommends monitoring blood glucose every 3-4 hours to assess glycemic control and adjust therapy as needed 1
The European Association for the Study of Diabetes recommends metformin as the initial pharmacologic treatment of choice for patients with type 2 diabetes and normal renal function 4

The American College of Physicians recommends evaluating for causes of hyponatremia, including fluid overload, medication effects, or syndrome of inappropriate antidiuretic hormone secretion, for patients with sodium levels of 130 mmol/L 1
The European Renal Association recommends correcting sodium levels gradually to avoid central pontine myelinolysis, with a target correction rate of no more than 8-10 mmol/L in 24 hours 1

The American College of Physicians recommends scheduling follow-up within 1-2 weeks to reassess laboratory values and adjust therapy as needed 1
The American Heart Association recommends considering continuous cardiac monitoring if metabolic acidosis worsens (pH < 7.0, bicarbonate < 10 mmol/L) to detect arrhythmias early 5
The American Diabetes Association recommends providing diabetes self-management education if hyperglycemia persists 1

The American College of Physicians recommends avoiding rapid correction of metabolic abnormalities, particularly sodium, as this can lead to neurological complications 1
The American Association of Clinical Endocrinologists recommends being vigilant for signs of diabetic ketoacidosis or hyperosmolar hyperglycemic state, including mental status changes, dehydration, and abdominal pain 1
The National Kidney Foundation recommends considering the impact of renal function on medication dosing, particularly for antidiabetic agents 2

The FDA explicitly states that metformin is contraindicated in patients with eGFR <30 mL/min/1.73 m² and should not be initiated in patients with eGFR <45 mL/min/1.73 m² 6
Metformin is cleared by renal filtration, and very high circulating levels due to impaired renal clearance have been associated with lactic acidosis 7

The FDA drug label warns that metformin should be discontinued in patients presenting with acute conditions associated with lactic acidosis, such as cardiogenic or distributive shock 8
Insulin therapy would be mandatory regardless of metformin contraindications if severe hyperglycemia were present (≥300 mg/dL or A1C ≥10%) 7, 9

If eGFR <45 mL/min/1.73 m², do not initiate metformin 6
If eGFR 30-45 mL/min/1.73 m², metformin may be continued if already on it, but should not be started 6

If renal function is confirmed normal (eGFR ≥45 mL/min/1.73 m²) and sodium normalizes, metformin becomes the preferred initial pharmacologic treatment 7, 9

Never start metformin without accurate assessment of renal function - the low creatinine may reflect decreased muscle mass rather than excellent kidney function 6
Do not use metformin in patients with active metabolic derangements that could precipitate lactic acidosis, even if chronic kidney disease is not present 8
Temporarily discontinue metformin before any iodinated contrast imaging procedures in patients with eGFR 30-60 mL/min/1.73 m² 6